Followers | 0 |
Posts | 1151 |
Boards Moderated | 0 |
Alias Born | 07/10/2003 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, August 31, 2003 6:47:42 AM
"Tony inedicated it took one year just to come to a working agreement,that puts us at Nov,2002. A 1 year term puts it at Nov.,2003 completed".
In November 2001, NYU's Mary Lea Johnson Richards Organ Transplantation Center agreed to provide us with informed consent qualified patient specimens and matching clinical data. We will genetically screen the specimens for markers
and/or marker sets that can be used to distinguish between drug responders and non-responders. To do this, we will employ proprietary genotyping protocols, data resources (the PHENOME SNP database) and our informatics platform. The goal of the project is to identify pharmacogenomic classifiers that could be used to match renal transplantation patients with the optimal immunosuppressant for their genetic architecture. We expect the project to take about one year to complete, and we expect the results to extend to patients for a wide range of transplantation procedures. The Mary Lea Johnson Richards Organ Transplantation Center is one of the busiest and most successful transplant programs in the United States
FEATURED Element79 Gold Corp Provides Update on Nevada Portfolio • Aug 23, 2024 8:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM